Learn if You Have a Claim Against Bristol-Myers Squibb Co.

Bristol-Myers Squibb Pulls Antibiotic Tequin Bristol-Myers Squibb confirms that the antibiotic Tequin, which has been linked to serious blood sugar complications, is being taken off the market. The company will stop making and selling the drug and return its rights to Kyorin Pharmaceutical Company in Japan.
Please explain any problems you have had in relation to this case:

Personal Information

First Name

Last Name

Street / Apt /

City, State Zip

Home Phone & Evening Phone (Same) . . & . .

E-Mail Address

Confirm E-Mail

Date Issue/Problem

Terms & Conditions
I acknowledge that I have read and understand and agree to the following legal policies.

Certain features of Lawcash.com require a login - please simply choose a password to continue.

Password

Confirm Password

I'd like to become a Lawcash.com member, receive a free class action ebook, and free class action and recall alerts. Billions of dollars are available each year and I'd like to claim my fair share from bad corporations.

Submit

Other Drugs / Medical Cases of Interest

Oxycontin Maker Purdue Pharma Charged with Acquiring Fraudulent Patents to Extend Drug Monopoly

Numerous drug companies have recently been charged with requesting fraudulent patents. A class action has been filed against Purdue Pharma, LP, the manufacturer of the popular painkiller, OxyContin, on the behalf of purchasers who allege that the company fraudulently secured patents on the drug in an effort to stave off cheaper generic competition.

Intermune to Pay $37 Million for Promotion of Actimmune Drug

InterMune Inc., a biopharmaceutical company based out of California, has agreed to pay the government $36.9 million to resolve criminal charges and civil liabilities in connection with allegations of illegally promoting Actimmune for treatment of idiopathic pulmonary fibrosis (IPF).

Shareholder Lawsuit Filed Against D&K Healthcare Resources

Several class actions have been filed against pharmaceuticals and healthcare supply wholesaler D&K Healthcare Resources, Inc. (Nasdaq:DKHR) and certain of its officers and directors by stockholders who purchased the company's common stock between April 23, 2001, and September 16, 2002. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities.

Sutter Health Settles Class Action

Sutter Health settled a class-action lawsuit related to its billing of uninsured patients, under which the system agrees to abide by its charity-care policy, adopted in March 2006, for at least three more years.

Los Angeles Woman Files Lawsuit Over Frey's "A Million Little Pieces"

A woman filed a proposed class-action lawsuit in Los Angeles against writer James Frey over his controversial memoir about his recovery from drug and alcohol abuse, court papers showed.

Biopure Back in Court Over Alleged Misrepresentations Made About Hemopure Blood Replacement Product

Several class actions have been filed against biotechnology company Biopure Corporation (Nasdaq:BPUR) and certain of its officers and directors by stockholders who purchased the company's common stock between March 17, 2003, and December 24, 2003. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations regarding Biopure’s blood replacement product to the market over this time period, thereby artificially inflating the price of the company's securities.